ACUPHARMA ApS: Financial statements 2013
CVR: 10072956
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 573,692 and a net result of DKK -39,410 compared with DKK -227,134 the year before. That is an increase of 57.3% compared with the year before. Equity in the 2013 report amounted to DKK 221,582. The solvency ratio was 14%.
- Gross Profit
- DKK 573,692
- Profit/Loss
- DKK -39,410
- Equity
- DKK 221,582
- Total Assets
- DKK 1,580,298
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 574 t. | -39 t. | 222 t. | - |
| 2012 | - | 365 t. | -227 t. | 261 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ACUPHARMA ApS has published its annual report for 2012. Gross profit came to DKK 364,777, and the net result was DKK -227,134.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.